1. Home
  2. BYFC vs CELU Comparison

BYFC vs CELU Comparison

Compare BYFC & CELU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BYFC
  • CELU
  • Stock Information
  • Founded
  • BYFC 1946
  • CELU 2016
  • Country
  • BYFC United States
  • CELU United States
  • Employees
  • BYFC N/A
  • CELU N/A
  • Industry
  • BYFC Savings Institutions
  • CELU Biotechnology: Pharmaceutical Preparations
  • Sector
  • BYFC Finance
  • CELU Health Care
  • Exchange
  • BYFC Nasdaq
  • CELU Nasdaq
  • Market Cap
  • BYFC 70.3M
  • CELU 64.3M
  • IPO Year
  • BYFC 1996
  • CELU N/A
  • Fundamental
  • Price
  • BYFC $7.34
  • CELU $2.19
  • Analyst Decision
  • BYFC
  • CELU Strong Buy
  • Analyst Count
  • BYFC 0
  • CELU 1
  • Target Price
  • BYFC N/A
  • CELU $6.00
  • AVG Volume (30 Days)
  • BYFC 1.7K
  • CELU 133.2K
  • Earning Date
  • BYFC 10-28-2025
  • CELU 08-29-2025
  • Dividend Yield
  • BYFC N/A
  • CELU N/A
  • EPS Growth
  • BYFC N/A
  • CELU N/A
  • EPS
  • BYFC N/A
  • CELU N/A
  • Revenue
  • BYFC $33,412,000.00
  • CELU $44,590,000.00
  • Revenue This Year
  • BYFC N/A
  • CELU $23.29
  • Revenue Next Year
  • BYFC N/A
  • CELU N/A
  • P/E Ratio
  • BYFC N/A
  • CELU N/A
  • Revenue Growth
  • BYFC N/A
  • CELU 4.45
  • 52 Week Low
  • BYFC $5.71
  • CELU $1.00
  • 52 Week High
  • BYFC $9.46
  • CELU $5.22
  • Technical
  • Relative Strength Index (RSI)
  • BYFC 37.50
  • CELU 35.22
  • Support Level
  • BYFC $7.26
  • CELU $2.02
  • Resistance Level
  • BYFC $7.50
  • CELU $2.53
  • Average True Range (ATR)
  • BYFC 0.11
  • CELU 0.30
  • MACD
  • BYFC -0.05
  • CELU -0.13
  • Stochastic Oscillator
  • BYFC 10.35
  • CELU 8.54

About BYFC Broadway Financial Corporation

Broadway Financial Corp is active in the financial services domain. It is a savings and loan holding company in the United States. The Bank's business consists of deposits from the general public and using such deposits, together with borrowings and other funds, to make mortgage loans secured by residential properties and commercial real estate. Its deposits consist of passbook savings accounts, checking accounts, and negotiable order of withdrawal accounts, money market accounts and fixed-term certificates of deposit. The revenue is derived from interest income on loans and investments.

About CELU Celularity Inc.

Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from the bio-banking segment.

Share on Social Networks: